CardMedic – Fluent in Healthcare CardMedic – Fluent in Healthcare
Sign in Book a demonstration
Sign in

Pharma, research and medical devices

Patient programmes reach the people who can read them. Everyone else is missing from your data.

Pharma, research and medical devices: CardMedic in use in this setting.

The situation

Patient programmes produce a lot of written information, and it has to stay accurate and current across languages and formats. But there is a second problem underneath that one: the patients who cannot read the materials are the patients the programme never reaches, and they are missing from the results as well as the care.

What that costs

  • The materials reach people who read the programme language well. Everyone else drops out quietly.
  • Patients excluded by language, reading level, sight or hearing are under-represented in the data, so the programme looks more effective than it is.
  • Materials drift out of date across markets and formats.
  • Accessibility is added at the end, if at all, and rarely covers Easy Read or read-aloud.

How CardMedic fits

We turn an approved pathway into governed content, publish it in the languages and formats your patients actually need, keep updates controlled, and report aggregate use so you can see who the programme is reaching.

Three outcomes

  • 01

    Reach the groups you are missing

    Language, reading level, sight and hearing covered from the start, not retro-fitted.

  • 02

    Governed content

    Clinical authorship, versioning and named review ownership.

  • 03

    See who it reached

    Aggregate use by format and language, without patient data.

Take back control of the communication pathway

Your organisation – not a software vendor or a language-service provider – sets the approved communication options and the routing policy. CardMedic applies your rules and shows you what happened.

Built to the hardest standard

Built where the bar is highest, so the standard travels with it.

CardMedic was built inside acute NHS care, where a misunderstood instruction is a patient safety incident and every claim is examined by clinical governance, information governance and procurement before anyone signs anything.

That is a slow, demanding place to build. It is also the reason the platform arrives in pharma, research and medical devices already carrying assurance that would otherwise take years to establish.

  • Clinical safety Content authored or verified by clinicians, governed under a clinical safety framework with a named Clinical Safety Officer. Most sectors have no equivalent requirement.
  • Information governance Built to NHS DSPT, DTAC and UK GDPR expectations, with DPIA support and a documented sub-processor position.
  • Accessibility Designed for people excluded by language, literacy, cognition, hearing and sight – not retrofitted to pass an audit.
  • Evidenced in use Independently evaluated in live NHS services, with sample, setting and method published rather than summarised.

The same principle a defence or aerospace engineer would recognise: qualify against the most demanding requirement, and the adjacent ones are already met.